语言

China

中国 地图

查看印度查看巴西

省份

请在下方的农业企业信息库中进行搜索

行业

位置: 中国 - Shanghai - 行业- - SAILYBIO

  • 公司名称: SAILYBIO

  • 联系人:

  • 电话:

  • 行业: 实验室 Laboratory

  • 地址: 上2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai 2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai PUDONGXINGQU, Shanghi, 201315 China

  • E-mail:

  • Company category:

  • 员工数量:

  • 网站地址:

  • Last updated: 2026-03-23

纳税人编号:

营收:

公司介绍 ：

Shanghai Sailybio  medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio  medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio  medical Co.,Ltd. to continue to provide excellent services to everyone.

公司产品：